Skip to main content

Home/ Cancer/ Group items tagged Experimental

Rss Feed Group items tagged

Matti Narkia

Experimental Drug May Work In Many Cancers - 2 views

  •  
    "SCIENTISTS have shown that a new class of cancer drugs called PARP inhibitors, currently being tested in clinical trials to treat breast and ovarian cancer could have dramatic results when used to treat other solid tumours, according to work presented at the NCRI Cancer Conference today. "
Matti Narkia

BioVex To Announce Updated Survival Data From A Phase II Clinical Study Of OncoVEX GM-C... - 0 views

  •  
    BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced that updated survival data from its Phase II study in metastatic melanoma will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 29, 2009 - June 2, 2009 in Orlando, F
Matti Narkia

Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer gr... - 0 views

  •  
    PHILADELPHIA - Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
Matti Narkia

IL-7/IL-15 increases immune response, inhibits tumor development, metastases - 0 views

  •  
    MedWire News: Intralesional injection of interleukin (IL)-7 and IL-15 enhances the effects of radiofrequency thermal ablation (RFA) in inhibiting tumor development and metastases, animal study results show.

    RFA, used for the treatment of solid tumors and known for its localized tumor effects, may activate immune responses and thereby reduce the risk for local tumor recurrence or distant metastases through T cell stimulation.

    However, studies have suggested that additional adjuvant immunotherapy may improve the efficacy of RFA.

    This preclinical study, reported in Breast Cancer Research and Treatment, was conducted to evaluate the effect of addition of the cytokines IL-7 and IL-15 to RFA in models of breast cancer.
Matti Narkia

Cancer Journal: Latest cancer research Bio-engineered proteins: trial confirms new way ... - 0 views

  •  
    Re-engineering a protein that helps prevent tumours spreading and growing has created a potentially powerful therapy for people with many different types of cancer. In a study published in the first issue of EMBO Molecular Medicine, Canadian researchers modified the tumour inhibiting protein, von Hippel-Lindau (VHL), and demonstrated that it could suppress tumour growth in mice.
Matti Narkia

The controversial place of vitamin C in cancer treatment - ScienceDirect - Biochemical ... - 0 views

  •  
    The controversial place of vitamin C in cancer treatment.
    Verrax J, Calderon PB.
    Biochem Pharmacol. 2008 Dec 15;76(12):1644-52. Epub 2008 Sep 30. Review.
    PMID: 18938145
    doi:10.1016/j.bcp.2008.09.024    
Matti Narkia

A pilot clinical study of continuous intravenous a...[P R Health Sci J. 2005] - PubMed ... - 0 views

  •  
    A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
    Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA.
    P R Health Sci J. 2005 Dec;24(4):269-76.
    PMID: 16570523
Matti Narkia

Intravenous vitamin C as a chemotherapy agent: a r...[P R Health Sci J. 2004] - PubMed ... - 0 views

  •  
    Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.\nRiordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.\nP R Health Sci J. 2004 Jun;23(2):115-8.\nPMID: 15377059
Matti Narkia

Intravenously administered vitamin C as cancer therapy: three cases. - CMAJ. 2006 Mar 28 - 0 views

  •  
    Intravenously administered vitamin C as cancer therapy: three cases.\nPadayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M.\nCMAJ. 2006 Mar 28;174(7):937-42.\nPMID: 16567755 \ndoi:10.1503/cmaj.050346.
Matti Narkia

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive ... - 0 views

  •  
    Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.
    Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M.
    Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9. Epub 2008 Aug 4.
    PMID: 18678913
    doi: 10.1073/pnas.0804226105
Matti Narkia

Technology Review: Implant Makes Cells Kill Cancer - 0 views

  •  
    A new approach to cancer treatment called immunotherapy could spare patients at least some of the grueling battery of chemotherapy treatments by retraining the body's own defenders--the cells of the immune system--to recognize and destroy tumors. Now researchers at Harvard University have developed a simple way to do this inside the body: a polymer implant attracts and trains immune-system cells to go after cancer.

    The experimental approach has shown great success in animal studies, increasing the survival rate of mice with a deadly melanoma from 0 to 90 percent. The implant could also be used to treat diseases of the immune system such as arthritis and diabetes, and, potentially, to train other kinds of cells, including stem cells used to repair damage to the body.
Matti Narkia

High-dose vitamin C therapy: Renewed hope or false promise? -- Assouline and Miller 174... - 0 views

  •  
    High-dose vitamin C therapy: renewed hope or false promise?\nAssouline S, Miller WH.\nCMAJ. 2006 Mar 28;174(7):956-7. \nPMID: 16567756
Matti Narkia

Cancer therapy: When all else fails - health - 28 March 2007 - New Scientist - 0 views

  •  
    DCA, or dichloroacetic acid - New Scientist
Matti Narkia

Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's ... - 0 views

  •  
    Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's Disease -- Brewer 226 (7): 665 -- Experimental Biology and Medicine
1 - 14 of 14
Showing 20 items per page